Desmopressin oral solution and preparation method thereof
By optimizing the formulation and preparation process in the oral solution of desmopressin acetate, the dosage of antibacterial agents is reduced, and the problems of antibacterial agent toxicity and lack of suitable dosage forms in the prior art are solved, and a safe and stable oral solution is provided. , improve treatment compliance and individualized dose reduction to meet the needs of children and patients with dysphagia.
Patent Information
- Application Number
- CN202411005929.3
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-07-25
- Publication Date
- 2024-11-15
AI Technical Summary
The antibacterial agents used in the existing oral solution of desmopressin acetate are toxic to cells, especially in children with high safety risks, and lack suitable oral solution dosage forms, making it difficult to meet the treatment needs of children and patients with dysphagia. .
Using desmopressin acetate, antibacterial agent 1 (sodium hydroxybenzyl), antibacterial agent 2 (sodium hydroxybenzyl) and pH regulator, the pH value is prepared by specific formula composition and preparation process. 4.0-5.0 desmopressin oral solution reduces the amount of antibacterial agent and improves product safety and stability.
Achieve safer and more stable oral solution of desmopressin, reduce the dosage of antibacterial agents, improve product quality and treatment compliance, is suitable for children and patients with dysphagia, and enhances the individualization of decreasing doses. and efficacy.
Smart Images

Figure SMS_2 
Figure SMS_3 
Figure SMS_4
Abstract
Description
Technical Field
[0001] The invention belongs to the technical field of pharmaceutical preparations, and in particular relates to a desmopressin oral solution and a preparation method thereof. Background Art
[0002] Desmopressin is the active substance of desmopressin acetate, which belongs to pituitary hormones and related drugs. It is a structural analog of the natural pituitary hormone arginine vasopressin. It differs from arginine vasopressin mainly in the deamination of cysteine and the replacement of L-arginine with D-arginine. These changes lead to a significantly prolonged duration of antidiuretic effect and no vasopressor effect at clinical doses. In terms of antidiuretic effect, desmopressin is a potent molecule with an EC50 value of 1.6pg / mL. After oral administration, the pharmacological effect may last for 6-14 hours. Desmopressin is a first-line treatment for nocturnal enuresis in children that is unanimously recommended by domestic and international guidelines and consensus. It has been in clinical use for nearly 40 years, with a treatment response rate of 69.9%, significantly reducing the number of nocturnal bedwetting in children. Desmopressin acetate oral solution is suitable for the treatment of central diabetes insipidus and primary nocturnal enuresis in patients with normal urine concentrating ability (over 5 years old).
[0003] If enuresis is not treated in time, it often has adverse effects on the patient's physical and mental health, and even causes mental disorders, emotional disorders, and social disorders. In recent years, NE has received increasing attention from the society. Therefore, children with enuresis need to be treated as soon as possible once diagnosed. Multiple guidelines point out that desmopressin acetate is an antidiuretic hormone analog and is currently the first-line drug for the treatment of enuresis. At the same time, many literatures have shown that it has good efficacy and safety. Compared with other dosage forms, desmopressin oral solution has its advantages. It facilitates the administration of desmopressin and reduces the risk of reflux after administration in children and elderly patients. In addition, since the dissolution time of dosage forms such as tablets is not required, desmopressin is released quickly. Therefore, it can be considered that desmopressin acetate oral solution has a bright future, and its demand will continue to rise in the future clinical practice to meet the clinical needs of patients.
[0004] According to the 23rd batch of reference preparations (serial number 23-63) issued by the State Food and Drug Administration, the reference preparation is desmopressin acetate oral solution produced by the licensed manufacturer GP PHARM, SA in Germany, with a trade name of The specification is 360μg / mL (calculated as desmopressin). Its prescription composition is as follows:
[0005]
[0006] Note: Calculated as desmopressin: 360 μg / mL.
[0007] The existing prescription composition contains two antibacterial agents, sodium methylparaben and sodium propylparaben. Since antibacterial agents are obviously toxic to cells, their use in humans may pose safety risks, especially for children of different ages. The data on the safe exposure level of antibacterial agents is still limited. Therefore, antibacterial agents are generally not used or used as little as possible. When they have to be used, the safest type of antibacterial agent should be selected under the premise of ensuring product quality, and the number of types should be kept to a minimum and the dosage should be kept to a minimum effective amount.
[0008] At present, the dosage forms of desmopressin acetate on the market in China are mainly tablets, injections, nasal sprays, etc. Nocturnal enuresis is common in young children, and liquid is the most preferred dosage form for children, which is convenient for accurate dosing. At the same time, it can meet the treatment needs of patients with dysphagia and improve patient compliance with medication. There is no report on the preparation process of the oral solution dosage form of this variety.
[0009] Therefore, it is necessary to research and develop an oral solution preparation with simple process, higher safety and stable product quality, to reduce the dosage of antibacterial agents as much as possible, and to be suitable for children and meet the treatment needs of patients with dysphagia. Summary of the invention
[0010] The object of the present invention is to provide a desmopressin oral solution and a preparation method thereof.
[0011] The desmopressin oral solution provided by the present invention contains desmopressin acetate, bacteriostatic agent 1, bacteriostatic agent 2, pH regulator and purified water.
[0012] Furthermore, the desmopressin oral solution comprises the following raw materials: desmopressin acetate 0.4 mg / mL, antibacterial agent 1 1.47 mg / mL-1.89 mg / mL, antibacterial agent 2 0.154 mg / mL-0.198 mg / mL, pH regulator, and purified water.
[0013] Preferably, the desmopressin oral solution comprises the following raw materials: desmopressin acetate 0.4 mg / mL, antibacterial agent 1 1.68 mg / mL-1.89 mg / mL, antibacterial agent 2 0.176 mg / mL-0.198 mg / mL, pH regulator, and purified water.
[0014] Furthermore, the antibacterial agent 1 is sodium methylparaben, and the antibacterial agent 2 is sodium propylparaben.
[0015] Furthermore, the pH regulator is dilute hydrochloric acid.
[0016] Furthermore, the pH value of the desmopressin oral solution is 4.0-5.0; further, the pH value of the desmopressin oral solution is 4.2-5.0; preferably, the pH value of the desmopressin oral solution is 4.6-4.8.
[0017] According to one embodiment of the present invention, the desmopressin oral solution comprises the following raw materials: 0.4 mg / mL, antibacterial agent 1 1.68 mg / mL, antibacterial agent 2 0.176 mg / mL, pH regulator, and purified water.
[0018] The present invention also provides a method for preparing the above-mentioned desmopressin oral solution, comprising the following steps:
[0019] (1) Add purified water to 65-80% of the total mass and start stirring;
[0020] (2) Add the prescribed amount of sodium methylparaben and sodium propylparaben in sequence and stir until completely dissolved;
[0021] (3) Add the prescribed amount of desmopressin acetate and stir until completely dissolved;
[0022] (4) adding a pH regulator to adjust the pH value of the solution;
[0023] (5) Add purified water to make up to the full volume;
[0024] (6) Filter through a 0.22 μm filter membrane and fill.
[0025] Furthermore, the room temperature during the preparation process is 20-30°C.
[0026] Furthermore, the stirring and dissolving time in the preparation process is 5-10 minutes.
[0027] Furthermore, the pH adjuster is also added after step (2) and before step (3) to adjust the pH value of the solution to 5.0-6.0.
[0028] Preferably, the pH adjusting agent is adjusted twice, the first time before adding desmopressin acetate, the pH value of the solution is adjusted to 5.0-6.0, and the second time after adding desmopressin acetate, the pH value of the solution is adjusted to 4.0-5.0 (preferably the pH value is 4.2-5.0; more preferably the pH value is 4.6-4.8). By using the two pH adjustment methods, the product quality is more stable.
[0029] Compared with the prior art, the present invention has the following beneficial effects:
[0030] The desmopressin oral solution prepared by the present invention has stable product quality, a lower dosage of antibacterial agent in the formula, and is safer; the pH value range of the preparation is determined to be 4.0-5.0, and the product has good stability; the preparation process is simple, the process is short, the source of raw and auxiliary materials is easy to obtain and the cost is low, and it is suitable for commercial production; the oral solution dosage form can significantly improve treatment compliance, is more suitable for children and patients with dysphagia to take medicine, and can be taken directly, which can control drinking water to the greatest extent, ensure efficacy and improve safety; compared with other dosage forms, this dosage form provides a more individualized and more sophisticated dose reduction scheme, improves the response rate of drug treatment, reduces recurrence, and meets clinical needs. DETAILED DESCRIPTION
[0031] The present invention is further described in detail below in conjunction with specific embodiments, and the examples provided are only for illustrating the present invention, rather than for limiting the scope of the present invention. The examples provided below can be used as a guide for further improvements by those of ordinary skill in the art, and do not constitute a limitation of the present invention in any way.
[0032] The experimental methods in the following examples, unless otherwise specified, are all conventional methods, and are performed according to the techniques or conditions described in the literature in the field or according to the product instructions. The materials, reagents, etc. used in the following examples, unless otherwise specified, can all be obtained from commercial channels.
[0033] Embodiment 1-10:
[0034] The prescription composition of the desmopressin oral solution in Examples 1-10 and Comparative Examples 1-2 is shown in Table 1.
[0035] Table 1 Prescription composition of desmopressin oral solution
[0036]
[0037]
[0038] The preparation processes of Examples 1-10 are the same, specifically:
[0039] (1) Add purified water to 70% of the total mass, start stirring, the stirring rate is 225 rpm, and the temperature is 20-30°C;
[0040] (2) Add the prescribed amount of sodium methylparaben and sodium propylparaben in sequence and stir until completely dissolved. The stirring time for the solution is 5-10 minutes;
[0041] (3) Add the prescribed amount of desmopressin acetate and stir until completely dissolved. The stirring time for the solution is 5-10 minutes;
[0042] (4) adding dilute hydrochloric acid to adjust the solution pH to 4.6-4.8;
[0043] (5) Add purified water to the full volume and stir for 5-10 minutes;
[0044] (6) Filter through a 0.22 μm filter membrane and fill.
[0045] The preparation process of the desmopressin oral solution in Comparative Example 1-2 is the same as that in Example 1-10, except that nitrogen is filled throughout the preparation process.
[0046] 1. Product Quality Evaluation of Desmopressin Oral Solution in Examples 1-10 and Comparative Example 1-2
[0047] Table 2 Desmopressin oral solution 0 day test results
[0048] Test items Characteristics content% Maximum single impurity % Total impurities% Example 1 Clear solution 96.1 0.019 0.049 Example 2 Clear solution 99.3 0.013 0.049 Example 3 Clear solution 101.4 0.013 0.049 Example 4 Clear solution 101.7 0.014 0.051 Example 5 Clear solution 102.3 0.015 0.050 Example 6 Clear solution 103.2 0.016 0.053 Example 7 Clear solution 101.8 0.019 0.048 Example 8 Clear solution 98.4 0.018 0.048 Example 9 Clear solution 102.6 0.013 0.048 Example 10 Clear solution 98.6 0.013 0.037 Comparative Example 1 Clear solution 102.6 0.013 0.048 Comparative Example 2 Clear solution 98.6 0.013 0.036
[0049] Table 3 Desmopressin oral solution 40 ℃ 30 days test results
[0050]
[0051]
[0052] Table 4 Desmopressin oral solution light 14 days test results
[0053] Test items Characteristics content% Maximum single impurity % Total impurities% Example 1 Clear solution 92.3 0.181 0.299 Example 2 Clear solution 96.5 0.098 0.109 Example 3 Clear solution 98.5 0.026 0.103 Example 4 Clear solution 98.7 0.024 0.098 Example 5 Clear solution 100.7 0.021 0.089 Example 6 Clear solution 101.7 0.025 0.092 Example 7 Clear solution 98.6 0.068 0.112 Example 8 Clear solution 94.5 0.147 0.146 Example 9 Clear solution 99.2 0.024 0.098 Example 10 Clear solution 95.7 0.029 0.106 Comparative Example 1 Clear solution 99.2 0.023 0.097 Comparative Example 2 Clear solution 95.8 0.029 0.104
[0054] Conclusion: After the sample without antibacterial agent was placed, the growth rate of related substances was greater than that of the sample with antibacterial agent. The product quality of Examples 3, 4, 5, 6, 9, and 10 was better. After the sample obtained by nitrogen filling during the preparation process of Comparative Examples 1 and 2 was placed, the product quality was not better than that of the examples.
[0055] 2. Antibacterial efficacy test of some examples
[0056] Table 5 Desmopressin oral solution antibacterial efficacy test results
[0057]
[0058]
[0059] Note: NI no growth means that the increase in the number of test bacteria does not exceed 0.5lg in the previous measurement time.
[0060] Conclusion: In Examples 4-6, two antibacterial agents were added at the same time, and the antibacterial effect was good; in Example 3, the dosage of the two antibacterial agents was low, and the antibacterial effect judgment standard was achieved with the use of sodium methylparaben alone in Example 9, but the antibacterial effect was relatively weak; in Example 10, sodium propylparaben was used alone, and the antibacterial effect judgment standard was not achieved. In Comparative Examples 1 and 2, nitrogen filling was performed throughout the process, and the antibacterial effect was increased, but the effect was not obvious. Considering the commercialization cost, nitrogen filling protection was not required in the preparation process.
[0061] Embodiment 11-16:
[0062] According to the dosage of the formula in Example 5, the pH value of the solution was investigated.
[0063] The prescription compositions of the desmopressin oral solutions of Examples 11-16 are shown in Table 6.
[0064] Table 6 Prescription composition of desmopressin oral solution
[0065]
[0066] The preparation processes of Examples 11-16 are the same, specifically:
[0067] (1) Add purified water to 70% of the total mass, start stirring, the stirring rate is 225 rpm, and the temperature is 20-30°C;
[0068] (2) Add the prescribed amount of sodium methylparaben and sodium propylparaben in sequence and stir until completely dissolved. The stirring time for the solution is 5-10 minutes;
[0069] (3) Add the prescribed amount of desmopressin acetate and stir until completely dissolved. The stirring time for the solution is 5-10 minutes;
[0070] (4) adding dilute hydrochloric acid to adjust the solution pH to 3.79, 4.21, 4.38, 4.68, 4.80, or 5.01;
[0071] (5) Add purified water to the full volume and stir for 5-10 minutes;
[0072] (6) Filter through a 0.22 μm filter membrane and fill.
[0073] Table 7 0-day test results of desmopressin oral solution at different pH values
[0074]
[0075]
[0076] Table 8 Test results of desmopressin oral solution at different pH values at 40°C for 30 days
[0077] Test items Characteristics pH Maximum single impurity % Total impurities% Embodiment 11 Clear solution 4.02 0.541 1.028 Example 12 Clear solution 4.46 0.196 0.796 Embodiment 13 Clear solution 4.77 0.098 0.509 Embodiment 14 Clear solution 5.06 0.072 0.391 Embodiment 15 Clear solution 5.15 0.069 0.429 Example 16 Clear solution 5.19 0.068 0.435
[0078] Table 9 Results of 14-day light test of desmopressin oral solution with different pH values
[0079] Test items Characteristics pH Maximum single impurity % Total impurities% Embodiment 11 Clear solution 3.84 0.072 0.221 Example 12 Clear solution 4.26 0.038 0.128 Embodiment 13 Clear solution 4.53 0.028 0.101 Embodiment 14 Clear solution 4.79 0.019 0.082 Embodiment 15 Clear solution 4.87 0.025 0.096 Example 16 Clear solution 5.09 0.027 0.104
[0080] Conclusion: The pH value of the finished product of Example 11 is low, and the growth of related substances is the largest; the growth of related substances in Example 14 is the smallest under light and 40°C conditions; the pH value range is determined to be 4.0-5.0; more preferably 4.6-4.8.
[0081] Embodiment 17-22:
[0082] According to the dosage of the formula in Example 5, the order of adding materials was investigated.
[0083] Table 10 Feeding sequence investigation and evaluation results
[0084]
[0085]
[0086] Conclusion: The addition order is different. The maximum single impurity and total impurity of Examples 19 and 20 are larger. In the preparation process, sodium methylparaben and sodium propylparaben are added first, and then desmopressin acetate is added. The pH value of the solution is adjusted twice, and the related substances of the sample are relatively small.
[0087] Embodiment 23-25:
[0088] The preparation temperature, mixing time and long-term stability were investigated. The prescription compositions of the desmopressin oral solutions of Examples 23-25 are shown in Table 11.
[0089] Table 11 Prescription composition of desmopressin oral solution
[0090]
[0091] The preparation processes of Examples 23-25 are the same, specifically:
[0092] (1) Add purified water to 70% of the total mass, start stirring at a stirring rate of 225 rpm, and use a water bath to heat at 20°C, 30°C, and 40°C;
[0093] (2) Add the prescribed amount of sodium methylparaben and sodium propylparaben in sequence and stir until completely dissolved;
[0094] (3) adding dilute hydrochloric acid to adjust the solution pH to 5.0-6.0;
[0095] (4) Add the prescribed amount of desmopressin acetate and stir until completely dissolved, and adjust the pH value of the solution to 4.6-4.8;
[0096] (5) Add purified water to the full volume and stir; take samples from the upper, middle, and lower layers of the solution after stirring for 5 and 10 minutes, respectively, to test the uniformity of the content;
[0097] (6) Filter through a 0.22 μm filter membrane and fill.
[0098] Table 12 Liquid preparation temperature investigation results
[0099] Test items Liquid preparation temperature Characteristics content% pH Maximum single impurity % Total impurities% Embodiment 23 20℃ Clear solution 100.7 4.77 0.022 0.056 Embodiment 24 30℃ Clear solution 100.6 4.76 0.023 0.057 Embodiment 25 40℃ Clear solution 100.9 4.78 0.020 0.054
[0100] Table 13 Results of the mixing and stirring time for liquid preparation
[0101]
[0102] Table 14 Results of a 12-month long-term stability test of desmopressin oral solution (30°C ± 2°C, relative humidity 65% ± 5%)
[0103] Test items Characteristics content% pH Maximum single impurity % Total impurities% Microbial Limits Embodiment 23 Clear solution 98.8 5.06 0.37 0.63 Comply with regulations Embodiment 24 Clear solution 99.4 4.94 0.24 0.58 Comply with regulations Embodiment 25 Clear solution 99.6 4.93 0.22 0.55 Comply with regulations Reference preparation Clear solution 97.5 5.23 1.08 2.16 /
[0104] Conclusion: There is no significant difference in the relevant substances when preparing solutions at 20℃, 30℃ and 40℃, and the raw and auxiliary materials are easily soluble in water. No heating is required during the preparation process, and the preparation temperature can be controlled at room temperature of 20-30℃. After adding purified water to the full amount, stirring for 5-10 minutes can make the solution content uniform. The results of the long-term stability test show that the product properties, content, pH value and related substances have not changed significantly, the microbial limits meet the regulations, meet the quality requirements, and the product quality is stable.
[0105] The desmopressin oral solution prepared by the prescription and method of the present invention has stable quality, and the dosage range of the antibacterial agent can meet the product quality requirements, reducing the amount of the antibacterial agent used, and further improving the safety of the product. The preparation process is simple, the process is short, the source of raw and auxiliary materials is easy to obtain and the cost is low, which is suitable for commercial production; the oral solution dosage form has a precise dosage, is more suitable for children and patients with dysphagia to take medicine, and meets clinical needs.
[0106] The present invention has been described in detail above. It will be apparent to those skilled in the art that the present invention may be implemented in a wide range under equivalent parameters, concentrations and conditions without departing from the spirit and scope of the present invention and without the need for unnecessary experimentation. Although the present invention provides specific embodiments, it should be understood that further improvements may be made to the present invention. In short, according to the principles of the present invention, this application intends to include any changes, uses or improvements to the present invention, including changes made by conventional techniques known in the art that depart from the scope disclosed in this application. Applications of some of the basic features may be made within the scope of the following appended claims.
Claims
1. A desmopressin oral solution, comprising the following raw materials: 0.4 mg / mL of desmopressin acetate, 11.47 mg / mL-1.89 mg / mL of antibacterial agent 1, 0.154 mg / mL-0.198 mg / mL of antibacterial agent 2, a pH regulator, and purified water; the antibacterial agent 1 is sodium methylparaben, and the antibacterial agent 2 is sodium propylparaben.
2. The desmopressin oral solution according to claim 1, characterized in that: The desmopressin oral solution comprises the following raw materials: 0.4 mg / mL desmopressin acetate, 1.68 mg / mL-1.89 mg / mL antibacterial agent, 20.176 mg / mL-0.198 mg / mL antibacterial agent, pH regulator, and purified water.
3. The desmopressin oral solution according to claim 1 or 2, characterized in that: The pH regulator is dilute hydrochloric acid.
4. The desmopressin oral solution according to any one of claims 1 to 3, characterized in that: The pH value of the desmopressin oral solution is 4.0-5.0; further, the pH value of the desmopressin oral solution is 4.2-5.0; preferably, the pH value of the desmopressin oral solution is 4.6-4.
8.
5. The desmopressin oral solution according to any one of claims 1 to 4, characterized in that: The desmopressin oral solution is prepared according to the method according to any one of claims 6-10.
6. The method for preparing the desmopressin oral solution according to any one of claims 1 to 4, comprising the following steps: (1) Add purified water to 65-80% of the total mass and start stirring; (2) adding sodium methylparaben and sodium propylparaben in sequence and stirring until completely dissolved; (3) adding desmopressin acetate and stirring until completely dissolved; (4) adding a pH regulator to adjust the pH value of the solution; (5) Add purified water to make up to the full volume; (6) Filter through a 0.22 μm filter membrane and fill.
7. The preparation method according to claim 6, characterized in that: The preparation process of the method is carried out at room temperature of 20-30°C.
8. The preparation method according to claim 6 or 7, characterized in that: The stirring time until complete dissolution is 5-10 minutes.
9. The preparation method according to any one of claims 6 to 8, characterized in that: In the step (4), the pH value of the solution is adjusted to 4.0-5.0; further, the pH value of the solution is adjusted to 4.2-5.0; preferably, the pH value of the solution is adjusted to 4.6-4.
8.
10. The preparation method according to any one of claims 9, characterized in that: The method further comprises the following step after step (2) and before step (3): adding the pH adjusting agent to the solution obtained in step (2) to adjust the pH value of the solution to 5.0-6.0.
